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The genes for firefly luciferase and chloramphenicol acetyltransferase (CAT) were used as reporter genes to explore the 
activation of heterologous promoters by 8-Br-cAMP. Cells were transfected with a CAT gene/tyrosine hydroxylase pro- 
moter, which contains a cAMP response lement. Extracts from cells treated with 8-Br-cAMP had 340% more enzyme 
activity than untreated cells. In contrast, reated cells transfected with a tyrosine hydroxylase/luciferase construct had 
30% less activity than control cells. Simian virus and rous sarcoma virus promoters/luciferase constructs also had lower 
activities in cells treated with 8-Br-cAMP than untreated cells. The inhibition of luciferase nzyme activity by cAMP 
appears to be posttranscriptional since both luciferase and CAT RNA levels were similarly increased incells treated with 
8-Br-cAMP or l-methyl-3-isobutylmethylxanthine. T e lower level of luciferase activity was not due to simple allosteric 
inhibition. We conclude that constructs using the firefly luciferase as a reporter gene are unsuitable for studying the effects 
of cAMP on the regulation of promoters. 
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1. INTRODUCTION 
The firely luciferase gene is being increasingly 
used as a reporter gene to explore the regulation of 
heterologous promoters (e.g. [1,2]). As such it of- 
fers a number of advantages over other reporter 
genes in that the luciferase nzyme assay is easy, 
sensitive, does not require radioactive material, 
and is amenable to automation [3]. However, the 
luciferase reporter gene has not been tested in as 
many situations as the most commonly used 
reporter gene, chloramphenicol acetyltransferase 
(CAT). We have tested the effect of a cAMP 
derivative on heterologous promoters fused to the 
luciferase reporter gene. 
A number of genes have been identified as being 
regulated at the transcriptional level by cAMP [4]. 
Two such genes are tyrosine hydroxylase (TH) and 
somatostatin. In this report we show that treat- 
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ment of transiently transfected cells by 8-Br-cAMP 
reduces the activity of various promoter/luciferase 
fusion genes. 
2. MATERIALS  AND METHODS 
2.1. Plasmids 
The somatostatin promoter linked to the CAT reporter gene 
was provided (pD(-71)CAT) by Dr M. Montminy (UCSD); 
pRSVCAT (rous sarcoma virus promoter/CAT) was provided 
by Dr B. Howard (NIH); pRSVL (rous sarcoma virus pro- 
moter/luciferase reporter gene), pSV232AL (an enhancerless si- 
mian virus promoter/luciferase) and pSVOAL (luciferase 
reporter gene) were gifts from Dr J. deWet (UCSD). To 
facilitate cloning we constructed a plasmid that contained an 
EcoRV site flanked by HindlII sites. An AluI fragment (27 to 
- 276) from the rat TH promoter was inserted into the EcoRV 
site [5]. This fragment was excised using HindlII and inserted 
in the proper orientation at the HindlII site of pSVOAL [3] 
creating prTHluc and into pSVOCAT, creating prTHCAT. 
2.2. Transfection 
Rat fibroblast cells (NIH 3T3) were grown in Dulbecco's 
modified Eagle's media supplemented with 10070 fetal calf 
serum. Rat pheochromocytoma cells (PCG2) were grown in the 
same media supplemented with 10°7o fetal calf and 5°70 horse 
serum. Cells (5 x l0 s) were transferred to 10-cm plates and 
transfected the next day using calcium phosphate-mediated 
transfection [6]. Cells were treated either with a mixture of test 
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plasmids (101tg) or with the test plasmid (20/zg) plus 
pRSVCAT or pRSVL (2/zg) as an internal control. 6 h later the 
cells were treated with 25% glycerol in media without serum for 
1 min, rinsed once and fresh complete media added. 
Isobutylmethylxanthine (IBMX; Sigma) and freshly prepared 
8-Br-cAMP (Sigma) were added to final concentrations of 
1 raM. The ceils were harvested 24 h later and assayed for 
luciferase [3] and CAT [7] enzyme ~activity or for RNA levels 
[8]. Luciferase activity was computed by measuring the height 
of the peak immediately after injection of ATP. 
3. RESULTS 
Extracts of  PCG2 cells transfected with 
prTHCAT and pD( -71)CAT (somatostat in pro-  
moter)  had 3 .4-5 .5- fo ld  higher levels of  CAT  ac- 
t ivity on treatment of  cells with 1 mM 8-Br -cAMP 
(fig. 1). In contrast,  extracts of  cell transfected with 
the same TH promoter  fragment placed in front of  
the luciferase reporter gene (prTHluc) treated with 
8-Br -cAMP had lower activities than untreated 
cells. To determine if the reduct ion in enzyme ac- 
t ivity was intrinsic to the TH promoter ,  we also ex- 
amined two viral promoters,  simian virus 
(pSV232AL delta 5 ' )  and rous sarcoma virus 
(pRSVL),  attached to luciferase gene. Treatment 
with 8-Br-cAMP of  cells transfected with both of  
these plasmids also resulted in lower enzyme ac- 
tivities than untreated cells. Similar results were 
obta ined when we used N IH  3T3 cells (not shown). 
In order to conf i rm and extend these results, 
PCG2 cells were cotransfected with prTHluc  and 
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Fig. 1. Effect of 8-Br-cAMP on luciferase and CAT activity. 
PCG2 cells were transfected with a mixture of test plasmid 
(20/~g) and the control plasmids, pRSVcat or pRSVL. After 
23 h incubation with 1 mM 8-Br-cAMP, cells were extracted 
and enzyme activities determined. Activities were normalized to 
respective control activities. Values are averages of 3 replicates 
(SE < 10O7o). 
prTHCAT and treated with the phosphodiesterase 
inhibitor,  IBMX,  and/or  8-Br -cAMP (fig.2). 
Treatment  with 8-Br -cAMP or with IBMX resulted 
in 6- and 8-fold enhancement o f  CAT  activity over 
that of  control .  Addi t ion  of  IBMX and 8-Br- 
cAMP resulted in higher levels than when either 
component  was added separately. In contrast,  
luciferase activity was not st imulated but was 
either reduced or remained the same when either 
IBMX or 8-Br -cAMP was added.  
To determine if the inhibit ion of  enzyme activity 
was transcr ipt ional  or posttranscr ipt ional ,  we 
assayed RNA from control  and treated cells. In 
contrast  to enzyme activities, the levels of  
luciferase and CAT RNAs were increased to a 
similar degree by treatment with either IBMX or 
8 -Br -cAMP (fig.2). 
To test whether the diminished activity was the 
result o f  inhibit ion of  luciferase nzyme activity by 
either 8-Br -cAMP or 8-Br -AMP,  we assayed com- 
mercial  luciferase (Sigma) in the presence of  
several dif ferent concentrat ions of  these reagents. 
F i ref ly luciferase has two active catalytic sites [9]; 
one site, Io, responds to addit ion of  ATP  by a 
rapid pulse of  activity and a rapid decay (within 
30-60  s). The second site, I1, is active at about 
10-20°70 of  I0 at saturat ing levels of  ATP  and per- 
sists over several minutes. Both AMP and cAMP 
are competit ive inhibitors of  ATP  at I0 [10] with Ki 
values of  0.25 and 0.9 mM, respectively. As shown 
in fig.3, 8 -Br -AMP when present at 0.25 mM in- 
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Fig.2. Effect of IBMX and 8-Br-cAMP on luciferase and CAT 
activity and RNA levels. PCG2 cells were transfected with a 
mixture of prTHCAT and prTHluc (10 jtg each). After 23 h 
incubation with 1 mM 8-Br-cAMP and/or 1 mM IBMX, cells 
were extracted and enzyme activities and RNA levels 
determined. Values are averages of 3 replicates (SE < 10%). 
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Fig.3. Effect of AMP derivatives on luciferase activity. 
Luciferase (30/zU) was assayed in the presence of various 
concentrations of 8-Br-AMP. ATP (final concentration 
4.0 raM) initiated the reaction. Squares, I0 activity; circles, I1 
activity. 
hibited I0 activity by 42% and had no effect on I1 
activity. In contrast, 8-Br-cAMP at a final concen- 
tration of  1 mM did not inhibit either site (not 
shown). 
To determine if cell extracts contained a com- 
pound that inhibited luciferase activity, commer- 
cial luciferase was preincubated for 5 min with 
extracts of  ceils that had been treated or untreated 
with 8-Br-cAMP. There was no effect on exo- 
genous luciferase activity demonstrating the 
absence of  any inhibitory compounds present in 
cell extracts. In contrast, we did find that certain 
preparations of  ATP  contained inhibitory com- 
pounds,  presumably AMP.  To minimize degrada- 
tion, stock solutions of  ATP  were rapidly adjusted 
to pH 7.0 and quick frozen. 
4. D ISCUSSION 
We and others have shown that cAMP 
derivatives increase the transcription of  TH and 
somatostat in /CAT reporter genes in transient ex- 
pression assays [11,12]. This increase in transcrip- 
tional activity is mediated by the presence of  a 
cAMP response element 5' to the TATA box in 
both of  these genes [4]. Surprisingly, when an iden- 
tical TH promoter fragment is fused to luciferase 
and CAT reporter genes very different responses 
are elicited by the presence of  8-Br-cAMP (fig. 1). 
In the same experimental" paradigm, CAT activity 
was increased in extracts f rom treated cells whereas 
luciferase activity was decreased in comparison to 
control  values (fig.2). Therefore, the reduction of  
luciferase activity upon addition of  8-Br-AMP 
does not appear to be due to the nature of  the at- 
tached promoter or the presence of  a cAMP 
response element as neither pSV232AL delta 5' 
nor pRSVL contain this sequence (fig. 1). Although 
luciferase can be inhibited by AMP derivatives 
(fig.3; [10]) our mixing experiments ruled out sim- 
ple inhibition of  enzyme activity by an allosteric in- 
hibitor such as 8-Br-AMP or AMP.  
Because RNA for both CAT and luciferase were 
induced to a similar degree upon the addition of  
either 8-Br-cAMP or IBMX (fig.3), the observed 
decrease in luciferase activity presumably involves 
its translational efficiency and/or  protein stability 
in the presence of  cAMP.  As firefly luciferase is in- 
timately involved in ATP  metabolism, it is not 
unreasonable to suggest hat cAMP may regulate 
luciferase protein levels via these mechanisms. 
Whatever the means of  inhibition, our data 
demonstrate that luciferase should not be used in 
examining the response of  heterologous promoters 
to cAMP.  
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